All Clinical Trials

Clinical Trial

Biologic effects and efficacy of Cerebellar tDCS in Children with Autism Spectrum Disorder

  • Recruiting participants (Starts Jan. 21, 2019)
  • Not accepting healthy volunteers
  • UTSW Principal Investigator: PETER TZU-SHIN TSAI

summary

Please refer to Section 3 of the protocol (Concise Summary of Project).

objective

Please refer to protocol sections "introduction and Purpose," "Background," "autism and the cerebellum," "non-invasive brain stimulation and autism," and "cerebellar non-invasive stimulation."

eligibility

-Ages 4 to 17, male and female, with known autism spectrum disorder as diagnosed by a clinician -This study may expose unborn children to risks, so females must not be pregnant. Approximately 30 milliliters of urine will be collected from females in the study for a pregnancy test. -- IQ Score no less than 1.5 Standard Deviations below the mean - Language Level (Speech consists of, at minimum, flexible, spontaneous, simple, sentences.)

Participate

If you are interested in this clinical trial, please contact Amy Magallanes on the Children’s Health Research Team.Call 214-648-5155Email